These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30248461)

  • 1. 2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.
    Nagaprashantha LD; Singhal J; Chikara S; Gugiu G; Horne D; Awasthi S; Salgia R; Singhal SS
    J Proteomics; 2019 Feb; 192():233-245. PubMed ID: 30248461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76.
    Singhal J; Chikara S; Horne D; Salgia R; Awasthi S; Singhal SS
    Mol Carcinog; 2018 Dec; 57(12):1751-1762. PubMed ID: 30136444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.
    Nagaprashantha LD; Singhal J; Li H; Warden C; Liu X; Horne D; Awasthi S; Salgia R; Singhal SS
    Oncotarget; 2018 Apr; 9(26):18053-18068. PubMed ID: 29719590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
    Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
    PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
    Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
    Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
    Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
    Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
    J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome.
    De Palma FDE; Del Monaco V; Pol JG; Kremer M; D'Argenio V; Stoll G; Montanaro D; Uszczyńska-Ratajczak B; Klein CC; Vlasova A; Botti G; D'Aiuto M; Baldi A; Guigó R; Kroemer G; Maiuri MC; Salvatore F
    Pharmacol Res; 2020 Nov; 161():105249. PubMed ID: 33068730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of talazoparib resistance in triple-negative breast cancer cells.
    Guney Eskiler G; Yanar S; Akpinar G; Kasap M
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22678. PubMed ID: 33325624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics as a Guide for Personalized Adjuvant Chemotherapy in Patients with Early Breast Cancer.
    Lumachi F; Chiara GB; Foltran L; Basso SM
    Cancer Genomics Proteomics; 2015; 12(6):385-90. PubMed ID: 26543084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RLIP inhibition suppresses breast-to-lung metastasis.
    Singhal J; Chikara S; Horne D; Salgia R; Awasthi S; Singhal SS
    Cancer Lett; 2019 Apr; 447():24-32. PubMed ID: 30684594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor.
    Sarwar M; Syed Khaja AS; Aleskandarany M; Karlsson R; Althobiti M; Ødum N; Mongan NP; Dizeyi N; Johnson H; Green AR; Ellis IO; Rakha EA; Persson JL
    Oncogene; 2019 Jan; 38(3):375-389. PubMed ID: 30104711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling.
    Breuer EK; Fukushiro-Lopes D; Dalheim A; Burnette M; Zartman J; Kaja S; Wells C; Campo L; Curtis KJ; Romero-Moreno R; Littlepage LE; Niebur GL; Hoskins K; Nishimura MI; Gentile S
    Cell Death Dis; 2019 Feb; 10(3):180. PubMed ID: 30792401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.
    Shetti D; Zhang B; Fan C; Mo C; Lee BH; Wei K
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.
    Zandberga E; Zayakin P; Ābols A; Pūpola D; Trapencieris P; Linē A
    Cancer Biol Ther; 2017 Aug; 18(8):596-605. PubMed ID: 28665755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.
    Zhou C; Zhong Q; Rhodes LV; Townley I; Bratton MR; Zhang Q; Martin EC; Elliott S; Collins-Burow BM; Burow ME; Wang G
    Breast Cancer Res; 2012 Mar; 14(2):R45. PubMed ID: 22417809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling vitamin D actions in triple negative/basal-like breast cancer.
    LaPorta E; Welsh J
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():65-73. PubMed ID: 24239860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer: Current Molecular Therapeutic Targets and New Players.
    Nagini S
    Anticancer Agents Med Chem; 2017; 17(2):152-163. PubMed ID: 27137076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.
    Zou W; Bai Y; Wang X; Cheng K; Sun H; Zhang G; Wang X; Yang Z
    Cancer Biother Radiopharm; 2017 Oct; 32(8):282-287. PubMed ID: 29053414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression.
    Moradi M; Gholipour H; Sepehri H; Attari F; Delphi L; Arefian E; Moridi Farimani M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2145-2156. PubMed ID: 32617603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.